HIVandHepatitis.com
HIV and AIDS Topics
Top News Articles
 
FDA-approved Treatments 
Experimental Treatments
Women / Children
Metabolic Complications
Opportunistic Infections
 Google Custom Search

National HIV/AIDS Atlas Maps the U.S. Epidemic

 Summary:
The National Minority Quality Forum (NMQF) has created a new online tool that shows what areas of the country have the most cases of HIV/AIDS.

The National HIV/AIDS Atlas presents county-level prevalence rates, based on the reported number of people living with HIV (but non AIDS) and AIDS in 2006. The map includes data for all 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands. Users can see their congressional and state legislative districts overlaid on top of the county-level data.

Mapping HIV/AIDS is an important step in stemming the tide of the disease, according to the web site. The Atlas was developed to increase awareness of, and public access to, HIV/AIDS data so people can better understand the reality of HIV/AIDS in the U.S. today.

The Atlas allows users to look at HIV/AIDS statistics according to sex, age, and race/ethnicity, where available, spotlighting the fact that African-Americans have disproportionately high rates in relation to their percentage of the total population. The map also reveals the impact of the epidemic in the southeast, as well as in states such as New York and California that have had a high burden of cases since the start of the epidemic.

"For the first time, we actually know where the patients are," said NMQF CEO Gary Puckrein. The organization has created similar atlases for other diseases including diabetes and cardiovascular disease.

The National AIDS Atlas is available free online at www.mapHIV.org.

6/26/09

Source
National Minority Quality Forum. Welcome to the National HIV/AIDS Atlas (www.mapHIV.org).


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Protease Inhibitors
Agenerase (amprenavir)
Aptivus
(tipranavir)
Crixivan
(indinavir)
Invirase
(saquinavir hard gel)
Kaletra
(lopinavir/ritonavir)
Lexiva
(fosamprenavir)
Norvir
(ritonavir)
Prezista
(darunavir)
Reyataz
(atazanavir)
Viracept
(nelfinavir)
Nucleoside / Nucleotide Reverse
Transcriptase Inhibitors
Combivir (zidovudine/lamivudine)
Epivir (lamivudine; 3TC)
Emtriva (emtricitabine; FTC)
Epzicom (abacavir + lamivudine)
Retrovir (zidovudine; AZT)
Trizivir (abacavir + zidovudine +lamivudine)
Truvada  (tenofovir / emtricitabine)
Videx (didanosine; ddI)
Viread (tenofovir)
Zerit (stavudine; d4T)
Ziagen (abacavir)
non Nucleoside Reverse
Transcriptase Inhibitors
Etravirine (Intelence; TMC125)
Rescriptor (delavirdine)
Sustiva (efavirenz)
Viramune (nevirapine)
Entry Inhibitors
(including Fusion Inhibitors)
Fuzeon (enfuvirtide, T-20)
Selzentry
(maraviroc)
Fixed Dose Combinations
Atripla (efavirenz + emtricitabine + tenofovir)
Combivir (zidovudine + lamivudine)
Trizivir (abacavir + zidovudine + lamivudine)
Truvada (tenofovir + emtricitabine)
Integrase Inhibitor
Isentress (raltegravir)